ACR Convergence 2020 Archives - Page 31 of 139

Abstract Number: 1603

P4 Index Correlates with RAPID3 and Disease-Specific Indices in Rheumatoid Arthritis (RA) and Axial Spondyloarthritis (axSpA)
Abstract Number: 0735

Paediatric Sarcoidosis: Phenotype of a Retrospective Cohort of Biopsy-proven Patients
Abstract Number: 1237

Pain and Other Patient-Reported Outcomes in Patients with Rheumatoid Arthritis Who Did or Did Not Achieve Treatment Response Based on Improvement in Swollen Joints in Tocilizumab Clinical Trials
Abstract Number: 1085

Pain in Myositis Is Associated with the Disease Activity
Abstract Number: 0028

Pain in the Time of Corona: Impact of COVID 19 Outbreak on Fibromyalgia Patients
Abstract Number: 1109

Pain in Women with Knee and/or Hip Osteoarthritis Is Related to Systemic Inflammation and to Adipose Tissue Dysfunction and Distribution: A Cross-sectional Metabolic Biomarkers Cohort Study
Abstract Number: 1030

Pain Medication Use Among Ankylosing Spondylitis and Psoriatic Arthritis Patients Before and After Initiation of Biologic Therapy
Abstract Number: 1490

Pain Rating Variability and Response to Treatment in Osteoarthritis Clinical Trials
Abstract Number: 1655

Pain Reduction Post Total Knee Replacement in Opioid Users and Non-users
Abstract Number: 0275

Paradoxical Relationship Between Disease Activity and Satisfaction with Care in Lupus
Abstract Number: 1979

Participant Engagement and Adherence in an ArthritisPower Real-World Study to Capture Smartwatch and Patient-Reported Outcome Data Among Rheumatoid Arthritis Patients
Abstract Number: 1000

Passive Smoking Throughout the Life Course and the Risk of Incident Rheumatoid Arthritis in Adulthood Among Women
Abstract Number: 0835

Pathogenic Effect of Chronic Stress-induced interleukin-12/23p40 on Neuropsychiatric System in Lupus-prone Mouse
Abstract Number: 0991

Pathogenic, Glycolytic PD-1+ B Cells Accumulate in the Hypoxic RA Joint
Abstract Number: 1394

Pathway to Systemic Sclerosis: Concerning Patients’ Experiences During the Diagnostic Process
Abstract Number: 0608

Patient and Parent Perspectives in a Academic Pediatric Rheumatology Transition Clinic
Abstract Number: 0593

Patient Characteristics and Factors Affecting Decision-Making Regarding Total Knee Replacement by Different Types of Physicians Treating Patients with Knee OA
Abstract Number: 0678

Patient Characteristics and Patterns of Urate-lowering Treatments in Older Patients with Incident Gout
Abstract Number: PP08

Patient Participation in the COVID-19 Global Rheumatology Alliance as a Model for Involving Patients from the Ground Up
Abstract Number: 1133

Patient Perceptions of Diagnosis, Tests, Treatments, Adherence and the Impact on Their Disease Understanding and Participation in Research Studies
Abstract Number: 1316

Patient Perceptions of Fibromyalgia Symptoms and the Overlap with Axial Spondyloarthritis
Abstract Number: 1131

Patient Perspective of Helpfulness of Lupus Medications: A Qualitative Study of Medication Use Within the Type 1 and 2 SLE Model
Abstract Number: 0256

Patient Perspective of the Type 1 and 2 SLE Model: A Qualitative Study
Abstract Number: 1130

Patient Perspectives on Biobanking and Data-linkage for Rheumatic Disease Research
Abstract Number: 1125

Patient Reported Impact of Lupus on Quality of Life
Abstract Number: 1494

Patient-Reported Adverse Events, Quality of Life and Treatment Adherence in Juvenile Idiopathic Arthritis: Analysis of Two Large International Cohorts
Abstract Number: 1769

Patient-reported COVID-19 Infection in Pregnant Women with Rheumatic Disease: Data from the COVID-19 Global Rheumatology Alliance Patient Experience Survey
Abstract Number: 0159

Patient-Reported Data Show the Impact of Time to Diagnosis in RA
Abstract Number: 1866

Patient-reported Impact of Axial Spondyloarthritis on Working Life. Results from the Spanish Atlas 2017
Abstract Number: 0169

Patient-Reported Outcomes Differentiate Between Remission and Low Disease Activity in Psoriatic Arthritis
Abstract Number: 0526

Patient-Reported Outcomes in Antiphospholipid Syndrome
Abstract Number: 1081

Patient-reported Outcomes in Early Autoimmune Inflammatory Myopathies
Abstract Number: 1241

Patient-Reported Outcomes in Rheumatoid Arthritis Patients Treated with Tofacitinib or Biological DMARDs in Real Life Conditions in Two Latin America Countries
Abstract Number: 1210

Patient-Reported Outcomes Measurement Information System (PROMIS) Assessment of Response to Treatment with Golimumab IV or Infliximab in Rheumatoid Arthritis Patients: Results from a Phase 4 Study
Abstract Number: 1728

Patient-Reported Outcomes of Upadacitinib versus Abatacept in Patients with Rheumatoid Arthritis and an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drugs: 12-Week Results of a Phase 3 Study
Abstract Number: 0011

Patients Receiving Cytokine Inhibitors Have Low Prevalence of SARS-CoV-2 Infection
Abstract Number: 1248

Patients Seropositive for La/SSB Without Ro/SSA Differ from Those Displaying La/SSB with Ro/SSA in a Single Center Sjogren’s Cohort
Abstract Number: 0193

Patients with Asthma Have a Higher Risk of Rheumatoid Arthritis: A Systematic Review and Meta-analysis
Abstract Number: 1739

Patients with Early Rheumatoid Arthritis Considered to Have a Favourable Risk Profile and Treated According to a Step-up Strategy Have an Increased Risk of Chronic Analgesic Consumption
Abstract Number: 1981

Patients with Inflammatory Arthritis Who Are More Adherent to Treatment Do Not Perform More Physical Activity Collected by Smartphone Apps: A Cross-sectional Study of 101 Patients, the ImBAIA Study
Abstract Number: 0362

Patients with Psoriatic Arthritis Treated with Guselkumab Achieved Psoriasis-Related Symptom-Free State and Had No Skin Condition Impact on Their Health Related Quality of Life
Abstract Number: PP10

Patients with Relapsing Polychondritis (“RP”) and an Advocate Manufactured Custom Cloth Masks to Combat COVID-19: This Mask Project Provided a Sense of Purpose, Created Unity, Increased Awareness of RP, Facilitated Research, and Generated Hope
Abstract Number: 1733

Patients with Rheumatoid Arthritis and Comorbid Depression Have High Levels of RAPID3 (Routine Assessment of Patient Index Data) and FAST3 (Fibromyalgia Assessment Screening Index) on a Multidimensional Health Assessment Questionnaire (MDHAQ)
Abstract Number: 1742

Patients’ and Rheumatologists’ Perceptions on Preventive Intervention in Rheumatoid Arthritis and Axial Spondyloarthritis
Abstract Number: 0146

Patients’ Perceptions and Expectations Towards the Role of Rheumatologists in the Recommendations of Physical Activity’s Practice – A Cross-sectional Study Involving 308 Patients Living with Rheumatoid Arthritis in France
Abstract Number: 1892

Pattern and Influential Factors in Promoting Treat-to-Target (T2T) for F Ankylosing Spondylitis (AS) Patients with the App of Smart System of Disease Management (SSDM): A Cohort Study from China
Abstract Number: 1958

Patterns and Impact of Long-term Glucocorticoid Use on RA Patients at Risk for Major Adverse Cardiac Events
Abstract Number: 1727

Patterns of Fatigue in Early RA over 10 Years: Results from the ESPOIR Cohort
Abstract Number: 1674

Pediatric and Adolescent One Year Protocol Kidney Biopsies Should Be Performed, Even in Patients with Complete Remission of Their Lupus Nephritis
Abstract Number: 0530

Pediatric APS: Clinical Features, Therapeutic Interventions, and Damage in a Series of 22 Cases
Abstract Number: 0791

Peficitinib Inhibits Angiogenesis via Suppression of VEGF Production in Rheumatoid Arthritis Fibroblast-like Synoviocytes
Abstract Number: 1267

Perceived Stress During the COVID-19 Pandemic Independently Associates with Worse Patient-Reported Outcomes in Systemic Lupus Erythematosus (SLE)
Abstract Number: 0586

Performance Characteristics of ANA by Elisa and Immunofluorescence
Abstract Number: 1885

Performance of SASDAS (Simplified Axial Spondyloarthritis Disease Activity Score) versus ASDAS in a Post Hoc Analysis of a Randomized Controlled Clinical Trial
Abstract Number: 1185

Performance of the MBDA-based CVD Risk Score in RA Patient Groups of Clinical Interest
Abstract Number: 1303

Performance of Three Referral Algorithms for Diagnosing Axial Spondyloarthritis: Results from the Screening in Axial Spondyloarthritis for Psoriasis, Iritis, and Colitis Cohort
Abstract Number: 1743

Perioperative Steroids in Rheumatoid Arthritis Patients Having Total Joint Replacements: Help or Harm?
Abstract Number: 0794

Peripheral Blood T and B Lymphocyte Subsets in Arthritis in the Elderly
Abstract Number: 1239

Peripheral Protein Biomarker Changes Following Selective Inhibition of Janus Kinase 1 (JAK1) by Filgotinib in Methotrexate Naïve Adults with Moderately-to-Severely Active Rheumatoid Arthritis
Abstract Number: 1286

Personalizing Cardiovascular Risk Prediction for Patients with Systemic Lupus Erythematosus by Physician Global Assessment of Disease Activity
Abstract Number: 1161

Perspectives of Radiologist Physicians in the Imaging of Chronic Nonbacterial Osteomyelitis
Abstract Number: 0148

Perspectives on Treatment Burden for Methotrexate and TNF-inhibitors Among Psoriatic Arthritis and Rheumatoid Arthritis Patients: A Qualitative Study
Abstract Number: 0619

Pharmacist Intervention: Reducing Insurance Denials of Specialty Medications
Abstract Number: 0133

Pharmacist-Driven Clinic Development for Patients with Incidental Vertebral or Hip Fractures
Abstract Number: 0438

Pharmacist-Led Multidisciplinary Approach to Opioid Tapering in a Large Private Rheumatology Practice
Abstract Number: 1041

Pharmaco-epidemiology of Non-infectious Ocular Inflammatory Disease in a Tertiary Academic Center
Abstract Number: 0204

Pharmacokinetics and Safety of CT-P17, a Proposed High Concentration (100 mg/mL) Adalimumab Biosimilar, in Comparison with EU-Approved Adalimumab and US-Licensed Adalimumab; Results of a Phase 1, Randomized, Double-blind, Three-arm, Single-dose Study in Healthy Subjects
Abstract Number: 0683

Pharmacokinetics of Pegloticase and Methotrexate Polyglutamate(s) in Patients with Uncontrolled Gout Receiving Pegloticase and Co-treatment of Methotrexate
Abstract Number: 0386

Phase 1 Clinical Study of MGTA-145 in Combination with Plerixafor Shows Rapid Single-Day Mobilization and Collection of CD34+ Hematopoietic Stem Cells Without G-CSF
Abstract Number: 1627

Phase I Trial of High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients with Mild COVID-19: A Study in the Effects of Shifting Public Opinion on Patient Enrollment
Abstract Number: 0781

Phenotypic and Functional Characterisation of Synovial Fluid-derived Fibroblast-like Synoviocytes in Rheumatoid Arthritis
Abstract Number: 0551

Physical Performance as a Mediator of the Association Between Depression and Pain in Knee Osteoarthritis
Abstract Number: 1385

Physical Therapy in Patients with Systemic Sclerosis: The Perspective of Physical Therapists on Current Delivery and Educational Needs
Abstract Number: 1146

Pilot Study of an Internet-Based Pain Coping Skills Training Program for Patients with Systemic Lupus Erythematosus
Abstract Number: 1601

Pilot Testing Supports Utility of a Point-of-Care Dashboard to Enhance Patient and Clinician Partnerships in the Management of RA
Abstract Number: 1645

Placebo Group Responses in Clinical Trials of Patients with Osteoarthritis: Data from the Tanezumab Development Program
Abstract Number: 1087

Plasma-derived Extracellular Vesicles Induced STING-mediated Proinflammatory Effects in Dermatomyositis
Abstract Number: 0763

Plasmatic Proteome in Individuals with Arthralgia at Risk of Developing Rheumatoid Arthritis
Abstract Number: 1792

Platelet-bound C4d Is Associated with an Increased Risk of Arterial and Venous Thromboses in SLE
Abstract Number: 1510

Platelet-bound C4d Is Associated with Platelet Activation and Arterial Thrombotic Events
Abstract Number: 1625

Pneumocystis Jiroveci Pneumonia in Immunocompromised Patients with Rheumatologic Disease in a Single, Tertiary Medical Center
Abstract Number: 1698

Polyarthritis Workup in Primary Care Setting : How Are We Doing?
Abstract Number: 0421

Polymyalgia Rheumatica Is Associated with Later Menopause: An Observational Study
Abstract Number: 0659

Polynesian-Specific Gout-Associated Frameshift Variant in PRPSAP1
Abstract Number: 0349

Pooled Safety Results from Two Phase-3 Trials of Guselkumab in Patients with Psoriatic Arthritis Through 1 Year
Abstract Number: 1395

Poor Maternal and Fetal Outcome in Indian Women with Systemic Sclerosis: Interview-based Study at a Tertiary Center in India
Abstract Number: 1692

Poor Physical Activity Levels and Cardiorespiratory Fitness Among Patients with Childhood-Onset Takayasu Arteritis in Remission
Abstract Number: 1951

Possible Involvement of Fractalkine/CX3CR1 Axis in Peripheral CD14++CD16+ Monocytes in Disease Development of Patients with Systemic Lupus Erythematosus
Abstract Number: 1006

Post-menopausal Rheumatoid Arthritis Is Inversely Associated with Lifetime High Level of Estrogen Exposure in the French E3N Cohort
Abstract Number: 1271

Post-Traumatic Stress Disorder (PTSD) and Risk of Systemic Lupus Erythematosus (SLE) Among Medicaid Recipients
Abstract Number: 0733

Practice Patterns for Tapering Medications in the Treatment of JIA-associated Uveitis
Abstract Number: 0692

Pre-Operative Opioid Usage Increases Length of Stay for Rheumatoid Arthritis Patients Undergoing Total Hip Arthroplasty and Total Knee Arthroplasty
Abstract Number: 0033

Pre-pregnancy Long Non-coding RNA Expression Signatures Among Women with Rheumatoid Arthritis Who Improve or Worsen During Pregnancy
Abstract Number: 1975

Predicting Bone Mineral Density of Lumbar Vertebrae by Assessing Plain Film with Deep Learning
Abstract Number: 1346

Predicting Major Treatment Response to Tumor Necrosis Factor Inhibitorsin Patients with Ankylosing Spondylitis
Abstract Number: 1722

Predicting Rheumatoid Arthritis Using the Symptoms in Persons at Risk of Rheumatoid Arthritis (SPARRA) Questionnaire
Abstract Number: 1117

Prediction Model for Progression to Different Find-Grained MRI-Based Osteoarthritis Severity States: The Vancouver Longitudinal Study of Early Knee Osteoarthritis (VALSEKO)
Abstract Number: 1294

Prediction of Damage in SLE Using Unbiased Analysis of Large Datasets
Abstract Number: 1752

Prediction of Responder and Non-responder to JAK Inhibitors in Patients with Rheumatoid Arthritis: A Pilot Study with Integrative Cluster Analysis
Abstract Number: 1987

Predictors of Adverse Outcomes in Patients with Childhood-Onset Systemic Lupus Erythematosus Transitioning to Adult Care
Abstract Number: 0717

Predictors of Clinical Remission in Children with Extended Oligoarticular Arthritis, Enthesitis-related Arthritis, or Psoriatic Arthritis Treated with Etanercept in the CLIPPER Studies
Abstract Number: 1163

Predictors of Colchicine Response in Patients with Undefined Systemic Autoinflammatory Diseases
Abstract Number: 0200

Predictors of Durable Clinical Response to Tofacitinib 11 Mg Once Daily with or Without Methotrexate in Patients with Rheumatoid Arthritis: Post Hoc Analysis of Data from a Phase 3b/4 Methotrexate Withdrawal Study
Abstract Number: 1935

Predictors of Early Mortality for Giant Cell Arteritis at the Time of Diagnosis
Abstract Number: 1288

Predictors of Frailty Identified by the Short Physical Performance Battery and Associations with Patient-reported Outcomes
Abstract Number: 0261

Predictors of Future Repeat Renal Biopsies in Patients with Lupus Nephritis and Influence of Repeat Biopsy in Flare Management: A Retrospective Study
Abstract Number: 2028

Predictors of Maintaining Inactive Disease After Etanercept Withdrawal, and Regaining Inactive Disease Status After Flare and Retreatment, in Adults with Non-radiographic Axial Spondyloarthritis: Results from RE-EMBARK
Abstract Number: 1347

Predictors of Response in Patients with Non-Radiographic Axial Spondyloarthritis Receiving Certolizumab Pegol in the C-axSpAnd Study
Abstract Number: 1893

Predictors of Response in Secukinumab-treated Patients with Ankylosing Spondylitis: Logistic Regression and Machine Learning Analyses
Abstract Number: 1475

Predictors of Thirty-Day Hospital Readmissions in Systemic Lupus Erythematosus in the US: A Nationwide Study
Abstract Number: 1716

Predictors of Unacceptable Pain and Unacceptable Pain with Low Inflammation in Early Rheumatoid Arthritis
Abstract Number: 1944

Predictors of Visual Loss and Cerebrovascular Accidents in Giant Cell Arteritis
Abstract Number: 1781

Pregnancy After Bariatric Surgery in Women with Rheumatic Diseases and Association with Adverse Birth Outcomes
Abstract Number: 1323

Pregnancy in Axial Spondyloarthropathy: A Systematic Review & Meta-Analysis
Abstract Number: 1498

Pregnancy Outcomes in Patients with Axial Spondyloarthritis – a First Analysis of a European Collaboration of Pregnancy Registries
Abstract Number: 1446

Pregnancy Outcomes in Patients with Interstitial Lung Disease
Abstract Number: 1639

Preliminary Baseline Subject Demographics and Disease Characteristics in a Phase 3 Clinical Trial of the Safety and Efficacy of Lenabasum in Dermatomyositis (DETERMINE)
Abstract Number: 2019

Preliminary Definition of a Positive MRI for Active Lesions in the Sacroiliac Joints Typical of Axial Spondyloarthritis
Abstract Number: 2020

Preliminary Definition of a Positive MRI for Structural Lesions in the Sacroiliac Joints in Axial Spondyloarthritis
Abstract Number: 0759

Presence of Ultrasound Imaging Biomarkers Are Good Predictors of Arthritis Development in a Population at Risk for Rheumatoid Arthritis
Abstract Number: 0860

PREVAIL 1: A Multiple Ascending Dose Study in Normal Healthy Volunteers of PRV-3279, a Novel Bispecific DART Molecule Targeting CD32B and CD79B on B Cells, with Potential for Treatment of SLE
Abstract Number: 1322

Prevalence and Associated Factors of Sleep Disorders in Patients with Axial Spondyloarthritis. Results from the European Map of Axial Spondyloarthritis (EMAS)
Abstract Number: 0401

Prevalence and Characteristics of Systemic Sclerosis Patients Fulfilling the 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus
Abstract Number: 0645

Prevalence and Clinical Features of COVID-19 in a Large Cohort of 199 Patients with Sarcoidosis
Abstract Number: 2015

Prevalence and Distribution of Peripheral Musculoskeletal Manifestations in Axial Spondyloarthritis, Peripheral Spondyloarthritis and Psoriatic Arthritis: Results of the International, Cross-sectional ASAS-PerSpA Study
Abstract Number: 1978

Prevalence and Factors Associated with Patient-Physician Discordance Among RA Patients Initiating Advanced Therapy
Abstract Number: 0166

Prevalence and Impact of Unacceptable Symptom State Among Patients with Psoriatic Arthritis: Results from the National Psoriasis Foundation’s 2019 Annual Survey
Abstract Number: 1758

Prevalence and Incidence of Infection and Venous Thromboembolism in Rheumatoid Arthritis Patients Newly Initiating Various DMARD Classes: Real-World Analysis of 2012–2016 US Medicare Data
Abstract Number: 0225

Prevalence and Probability Assessment of Adverse Drug Reactions in Rheumatoid Arthritis Patients Receiving Intravenous Originator Biologics in Saudi Arabia: A Longitudinal Five Years Follow-up Study
Abstract Number: 0264

Prevalence and Risk Factors Associated with Isolated Neutropenia in Outpatients with Systemic Lupus Erythematosus
Abstract Number: 0392

Prevalence and Survival of Systemic Sclerosis (SSc) and Associated Interstitial Lung Disease (ILD) in Ontario, Canada over 10 Years
Abstract Number: 1719

Prevalence and Trajectory of Erosions, Synovitis, and Bone Marrow Edema in Feet of Patients with Early Rheumatoid Arthritis
Abstract Number: 1025

Prevalence Estimates for Systemic Lupus Erythematosus over Four Decades
Abstract Number: 0394

Prevalence of a Diagnosis of Osteopenia/Osteoporosis Amongst Patients with Systemic Sclerosis and Identification of Associated Clinical Factors
Abstract Number: 1426

Prevalence of ANCA-associated Vasculitis and Spatial Association with Quarries in a French Northeast Region: A Capture-recapture and Geospatial Analysis
Abstract Number: 1066

Prevalence of Cervical Dysplasia in Women with Antisynthetase Syndrome
Abstract Number: 1313

Prevalence of Extra-Articular Manifestations in Early Ankylosing Spondylitis versus Non-Radiographic Axial Spondyloarthritis: A Systematic Literature Review and Meta-Analysis of 1504 Patients
Abstract Number: 1134

Prevalence of Frailty and Associated Factors in a National Observational Cohort of Rheumatic Diseases
Abstract Number: 0009

Prevalence of Hydroxychloroquine and Chloroquine Side Effects in Rheumatology Patients: A Retrospective Survey of 115 Cases
Abstract Number: 0185

Prevalence of Migraine and Neuropathic Pain in Rheumatic Disease
Abstract Number: 1287

Prevalence of Morbidity Prior to Diagnosis of Incident Systemic Lupus Erythematosus in the Danish Population
Abstract Number: 0132

Prevalence of Osteoporosis and Fragitlity Fractures Is Not Different Between ACPA Positive Patients Compared to ACPA Negative Patients in a Real World Setting, Despite Longer Disease Duration and Glucocorticoid-Treatment
Abstract Number: 1199

Prevalence of Subclinical Interstitial Lung Disease After a Mean Rheumatoid Arthritis Duration of 13 Years: Results from the French ESPOIR Cohort
Abstract Number: 0081

Prevalence of Systemic Autoimmune Diseases in Polycystic Ovary Syndrome
Abstract Number: 0418

Prevalence of Thyroid Disease Among Patients with Vasculitis
Abstract Number: 1543

Prevalence of Ultrasound Findings Suggestive of Inflammatory Arthritis in Children with Skin Psoriasis (ChildEchoPso)
Abstract Number: 1309

Prevalence of Undiagnosed Axial Spondyloarthritis Among Patients with Inflammatory Bowel Disease: A Secondary Care Cross-Sectional Study
Abstract Number: 0489

Prevalence, Incidence, and Cause-Specific Mortality of Rheumatoid Arthritis-Associated Interstitial Lung Disease Among Older Patients with Rheumatoid Arthritis: A Nationwide Cohort Study
Abstract Number: 0451

Prevalence, Therapy and Tumor Response in Patients with Rheumatic Immune-related Adverse Events Following Immune Checkpoint Inhibitor Therapy: A Single-Centre Analysis
Abstract Number: 1139

Primary Non-adherence in Patients with Systemic Lupus Erythematosus
Abstract Number: 1673

Principles of Pediatric Lupus Nephritis in a Contemporary Multi-Center Cohort
Abstract Number: 0021

Prioritizing Patient Safety While Maintaining Study Integrity During COVID-19: Lupus Intervention Fatigue Trial Modifications and Lessons Learned
Abstract Number: 1028

Probabilistic Linkage of a Cohort of Individuals with Symptoms Suggestive of Early Spondyloarthritis and the French National Healthcare Database
Abstract Number: 0905

Probability of Achieving Low Disease Activity or Remission with Apremilast Treatment Among DMARD-Naive Subjects with Active Psoriatic Arthritis
Abstract Number: 1635

Profile of Topical Diclofenac Sodium Gel 1% (Voltaren®) Users in a United States Longitudinal Electronic Health Records Database
Abstract Number: 1435

Prognostic Factors for Mononeuritis Multiplex Associated with ANCA-associated Vasculitis
Abstract Number: 1652

Progression of Knee OA with Use of Intra-articular Corticosteroids (CS) vs Hyaluronic Acid (HA)
Abstract Number: 0901

Proinflammatory Neutrophil Function Is Modulated During Secukinumab Therapy in Psoriatic Arthritis Without Compromising Host Defence
Abstract Number: 0018

PROMIS-29 and Health Related Quality of Life in Rheumatology Outpatients During the COVID-19 Pandemic in New York City
Abstract Number: 0137

PROMIS-29 Scores Are Significantly Higher in Patients with Rheumatoid Arthritis Who Meet Criteria for Co-morbid Fibromyalgia (FM) Than in Those with Rheumatoid Arthritis and No FM
Abstract Number: 1738

Promote Treat-to-Target for RA via Empowering Patients: A Cohort Study from China by Smart System of Disease Management (SSDM)
Abstract Number: 1368

Proportions of Patients Achieving a Minimal Disease Activity State upon Treatment with Tildrakizumab in a Psoriatic Arthritis Phase 2b Study
Abstract Number: 0832

PROSARA – A Prospective, Multicenter, Noninterventional Study to Evaluate the Safety and Effectiveness of Sarilumab for the Treatment of Active Rheumatoid Arthritis in Regular Care in Germany
Abstract Number: 1047

Prospective Analysis of a Cohort of Patients with Interstitial Lung Disease Associated with Connective Tissue Disease and Their Response to Immunosuppression with Mycophenolate Mofetil and Rituximab
Abstract Number: 1936

Prospective Analysis of Flow Velocity of the Central Retinal Artery in Newly Diagnosed Patients with Giant Cell Arteritis with Visual Symptoms and Controls
Abstract Number: 0420

Prospective Analysis of the Prevalence of Giant Cell Arteritis in Consecutive Newly Diagnosed Patients with Polymyalgia Rheumatica
Abstract Number: 0672

Prospective Study of the Patterns of Joint Involvement for Sequential Gout Flares
Abstract Number: 1002

Prostate Cancer Risk Is Not Increased in Rheumatoid Arthritis After Accounting for Retention in a Health Care System
Abstract Number: 0038

Protein Biomarkers May Differentiate Responders and Non-Responders to Adalimumab, a Tumour Necrosis Factor Inhibitor, in Ankylosing Spondylitis Patients – The Bioefficacy SpA Study
Abstract Number: 1439

Proteinase 3-Reactive B Cell Pool Restructuring After Rituximab and Risk of Relapse in Severe PR3-ANCA-Associated Vasculitis
Abstract Number: 0429

Prothrombotic Antiphospholipid Antibodies in COVID-19
Abstract Number: 0535

Provider Opinion and Support for Shared Decision-making in Gout Treatment: A Quality Improvement National Survey of Veterans Affairs Rheumatologists
Abstract Number: 1523

Pulmonary Cytokine, Chemokine and Growth Factor Profiles of Distinct Radiographic Patterns of Interstitial Lung Disease in Systemic Sclerosis
Abstract Number: 0279

Pulmonary Involvement in a Single Center Cohort of Patients with Systemic Lupus Erythematosus